Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Anesthesia
Interventions: Ambu AuraGain, Teleflex LMA Protector, Ambu aScope; Device
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tinnitus
Interventions: Lenire bimodal stimulation device; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Diabetic Macular Edema
Interventions: Triamcinolone Acetonide, Semi-automated Suprachoroidal Microcatheter; Drug · Device
Lead sponsor: Oxular Limited; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 6
States / cities: Bakersfield, California • Minneapolis, Minnesota • Austin, Texas + 2 more

Conditions: Atrial Fibrillation (AF)
Interventions: discontinue anticoagulation therapy, Anticoagulant drugs, Catheter Ablation; Behavioral · Drug · Procedure
Lead sponsor: China National Center for Cardiovascular Diseases; Government
Eligibility: 18 Years and older
Enrollment: 3,160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Sinusitis With or Without Nasal Polyps
Interventions: Fluticasone Propionate; Drug
Lead sponsor: Optinose US Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 705 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 18
States / cities: Phoenix, Arizona • Colorado Springs, Colorado • Largo, Florida + 15 more

Conditions: Multiple Sclerosis, Lung Cancer, Breast Cancer
Interventions: CT-100-D-004-A, CT-100-D-004-B; Device
Lead sponsor: Click Therapeutics, Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure
Interventions: Not listed
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 19 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Sensory Perceptual Characteristics, User Acceptability of Gel Delivery System
Interventions: PreBioGyn Gel, Trimosan Gel, RepHresh Gel; Other
Lead sponsor: Glyciome, LLC; Industry
Eligibility: 30 Years and older · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Aneurysm
Interventions: SHIELD; Device
Lead sponsor: Jacobs institute; Other
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Congestive Heart Failure, Atrial Arrhythmia, Atrial Tachyarrhythmia, Atrial Fibrillation
Interventions: Cardiac Resynchronization Therapy+Implantable Cardioverter Defibrillator; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 30
States / cities: Anchorage, Alaska • Phoenix, Arizona • Santa Monica, California + 27 more

Conditions: Stroke
Interventions: Monitored (M+); Device
Lead sponsor: AiCure; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Heat Transfer by Clinical Warming Devices
Interventions: Adult blanket plus, MA2220 blanket connected to the Mistral Air, Blower MA1200-PM system., Premium adult blanket, 3320 blanket connected to the Mistral Air, Blower MA1200-PM system., Blanket full body, 30000 blanket connected to the 3M, Bair Hugger, Blower 775, FilteredFlo® Air Blanket connected to the WarmAir® Convective Warming system., Blanket Full Body blanket (CLM0101) connected to the Care Essential, Cocoon, Blower CWS5000 system; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Healthy
Interventions: Nasal Glucagon Device (NG), GEK, IM Glucagon; Device · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Atrial Fibrillation (AF), Tachycardia, Bradycardia, PVC - Premature Ventricular Contraction, Premature Atrial Contraction
Interventions: Test Algorithm and Test Device; Device
Lead sponsor: Zywie, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Pseudofolliculitis Barbae
Interventions: 1064nm Nd:YAG laser at 12 J/cm2, 20 ms and 10mm spot size.; Procedure
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: San Diego, California

Conditions: High Risk Pregnancy
Interventions: In-Home Non-Stress Test Device; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: Koneksa Health; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 10
States / cities: Aurora, Colorado • Boca Raton, Florida • DeLand, Florida + 7 more

Conditions: Heart Failure
Interventions: Transcutaneous electrical stimulation, Neuromuscular electrical stimulation; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Sleep Related Breathing Disorder, Snoring, Obstructive Sleep Apnea (OSA), Open Bite, Occlusal Changes, Tooth Migration, Posterior Open Bite
Interventions: AM Aligner, Exercise; Device · Behavioral
Lead sponsor: Isabel Moreno Hay; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Gastrointestinal Complication
Interventions: PrevisEA device; Device
Lead sponsor: Entac Medical Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 8
States / cities: Orlando, Florida • Chicago, Illinois • Grand Rapids, Michigan + 5 more

Conditions: Pelvic Floor Disorders
Interventions: PFDx device and leva device; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma

Conditions: Contraception
Interventions: Copper IUD, Levonorgestrel IUD; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 6
States / cities: Logan, Utah • Ogden, Utah • Orem, Utah + 3 more

Conditions: Physiological Wellness
Interventions: NovoTHOR XL Photobiomodulation Full Body Light Bed, ARRC LED Photobiomodulation Full Body Light Bed; Device
Lead sponsor: United States Air Force Research Laboratory; Federal
Eligibility: 18 Years to 45 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Beavercreek, Ohio

Conditions: Unplanned Pregnancy
Interventions: Levonorgestrel-Releasing Intrauterine Contraceptive System (LNG-IUS), 52 Mg, 5 Year Duration; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients

Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus

Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure

Perception & Acceptability of a Cervical Cancer Prevention Prebiotic Device

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

Clinical Investigation of the Medtronic Concerto™ Device

Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

Heat Loss in Humans Covered With Full-Body Blankets Connected to Different Warming Devices

A Study Comparing User Experience of Different Delivery Devices for Glucagon

Evaluation of a Test Algorithm for Use to Analyze ECG Data Collected From a Test Device of a 24-hour Simulated Use Period

Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI

Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring

Parkinson's Disease Progression Study

Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)

IOA Preventing Occlusal Changes With MAD Use

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

Intravaginal Devices for Pelvic Floor Motion

RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC

Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices

A Pilot Study of Early Postpartum Intrauterine Contraception